Toggle navigation
Toggle navigation
About Inflarx
Leadership Team
Board
Company History
Vision
R&D
About Complement
About C5A
Technology
Pipeline
Clinical Development
Hidradenitis Suppurativa
Shine Study FAQ
ANCA-Associated Vasculitis
Pyoderma Gangraenosum
COVID-19
cSCC
Clinical Trials
Publications & Posters
Investors
Press Releases
Events & Presentations
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Annual/Extraordinary General Meetings
E-mail alerts
Career
Open Positions
Financial-Information
Home
Investors
Financial Information
Financial-Information InflaRx SEC filings and financial reports
The following list represents all InflaRx SEC filings and financial reports.
Select year:
2023
2022
2021
2020
2019
2018
2017
Filter filing type:
annual reports
registration statements (including forms F-1, F-3, prospectuses and S-8)
current reports (6-k), including quarterly reports
statements of beneficial ownership
other
all
Date
Filing Type
Filing Description
Download / View
2023-05-11
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-04-27
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-04-24
SC 13G
Statement of acquisition of beneficial ownership by individuals
2023-04-17
SC 13G
Statement of acquisition of beneficial ownership by individuals
2023-04-13
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-04-13
424B5
Prospectus [Rule 424(b)(5)]
2023-04-11
424B5
Prospectus [Rule 424(b)(5)]
2023-04-05
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-04-04
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-03-22
20-F
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023-03-22
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-02-13
SC 13G/A
Statement of acquisition of beneficial ownership by individuals
2023-01-05
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
